Dangsim K-7 (Korea Genetic Pharm Co., Ltd)


Welcome to the PulseAid listing for the Dangsim K-7 drug offered from Korea Genetic Pharm Co., Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Korea Genetic Pharm Co., Ltd
NON-PROPRIETARY NAME: MOMORDICA CHARANTIA FRUIT
SUBSTANCE NAME: MOMORDICA CHARANTIA FRUIT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: GRANULE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-02-07
END MARKETING DATE: 0000-00-00


Dangsim K-7 HUMAN OTC DRUG Details:

Item DescriptionDangsim K-7 from Korea Genetic Pharm Co., Ltd
LABELER NAME: Korea Genetic Pharm Co., Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: 13(g/100g)
START MARKETING DATE: 2012-02-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42707-1001_daca2668-d76f-4e0f-b7da-3224ffffdbae
PRODUCT NDC: 42707-1001
APPLICATION NUMBER:

Other MOMORDICA CHARANTIA FRUIT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Korea Genetic Pharm Co., LtdDangsim K-7